AT257634B - Verfahren zur Herstellung von neuen Guanidinderivaten und ihren Salzen - Google Patents

Verfahren zur Herstellung von neuen Guanidinderivaten und ihren Salzen

Info

Publication number
AT257634B
AT257634B AT1051066A AT1051066A AT257634B AT 257634 B AT257634 B AT 257634B AT 1051066 A AT1051066 A AT 1051066A AT 1051066 A AT1051066 A AT 1051066A AT 257634 B AT257634 B AT 257634B
Authority
AT
Austria
Prior art keywords
salts
production
guanidine derivatives
new guanidine
new
Prior art date
Application number
AT1051066A
Other languages
English (en)
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1007264A external-priority patent/CH448068A/de
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Application granted granted Critical
Publication of AT257634B publication Critical patent/AT257634B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT1051066A 1964-07-31 1965-07-30 Verfahren zur Herstellung von neuen Guanidinderivaten und ihren Salzen AT257634B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1007264A CH448068A (de) 1964-07-31 1964-07-31 Verfahren zur Herstellung von neuen Guanidinderivaten

Publications (1)

Publication Number Publication Date
AT257634B true AT257634B (de) 1967-10-10

Family

ID=4359025

Family Applications (3)

Application Number Title Priority Date Filing Date
AT707765A AT257632B (de) 1964-07-31 1965-07-30 Verfahren zur Herstellung von neuen Guanidinderivaten und ihrer Salzen
AT1050966A AT257633B (de) 1964-07-31 1965-07-30 Verfahren zur Herstellung von neuen Guanidinderivaten und ihren Salzen
AT1051066A AT257634B (de) 1964-07-31 1965-07-30 Verfahren zur Herstellung von neuen Guanidinderivaten und ihren Salzen

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT707765A AT257632B (de) 1964-07-31 1965-07-30 Verfahren zur Herstellung von neuen Guanidinderivaten und ihrer Salzen
AT1050966A AT257633B (de) 1964-07-31 1965-07-30 Verfahren zur Herstellung von neuen Guanidinderivaten und ihren Salzen

Country Status (8)

Country Link
US (1) US3270054A (de)
AT (3) AT257632B (de)
BE (1) BE667692A (de)
DE (1) DE1235904B (de)
ES (2) ES315990A1 (de)
FR (1) FR4976M (de)
GB (1) GB1063749A (de)
NL (2) NL6509927A (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH435243A (de) * 1964-03-26 1967-05-15 Geigy Ag J R Verfahren zur Herstellung von neuen N'-substituierten N-Arylsulfonyl-harnstoffen
NL6503019A (de) * 1965-03-10 1966-09-12
US3873717A (en) * 1970-11-20 1975-03-25 Ciba Geigy Corp Certain 2,2-dimethyl-propanal-carbamoyloximes fungicides
DD104782A1 (de) * 1972-05-29 1974-03-20
NL7307651A (de) * 1972-06-07 1973-12-11
US4007181A (en) * 1974-02-11 1977-02-08 The Upjohn Company Adamantyl containing guanidines
US5312840A (en) * 1986-07-10 1994-05-17 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education Substituted guanidines having high binding to the sigma receptor and the use thereof
US5502255A (en) * 1986-07-10 1996-03-26 State Of Oregon Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Substituted guanidines having high binding to the sigma receptor and the use thereof
US5336689A (en) * 1990-03-02 1994-08-09 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
KR100353486B1 (ko) 1990-03-02 2003-01-06 스테이트 오브 오레곤,액팅 바이 앤드 쓰로우 디 오레곤 스테이트 보드 오브 하이어 에주케이션,액팅포앤드 온 비해프 오브 디 오레곤 헬쓰 사이언시즈 유니버시티 앤드 더 유니버시티 오브 오레곤,유진,오레곤 삼치환및사치환된구아니딘류및이를함유하는약제조성물
US5262568A (en) * 1990-03-02 1993-11-16 State Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
EP0532642A1 (de) * 1990-05-25 1993-03-24 STATE OF OREGON, acting through OREGON STATE BOARD OF HIGHER EDUCATION, acting for OREGON HEALTH SC. UNIV. AND UNIV. OF OREGON Substituierte guanidine, welche eine hohe sigma-rezeptor-bindungsaffinität besitzen, und ihre verwendung
CA2099245A1 (en) * 1991-02-08 1992-08-09 Stanley M. Goldin Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5847006A (en) * 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
DK0705100T3 (da) * 1993-05-27 2003-11-17 Cenes Ltd Terapeutiske substituerede guanidiner
WO1995014461A1 (en) * 1993-11-23 1995-06-01 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
AU1912595A (en) * 1994-02-03 1995-08-21 Cambridge Neuroscience, Inc. Therapeutic guanidines
US7351743B1 (en) 1994-02-03 2008-04-01 Wyeth Therapeutic guanidines
US6787569B1 (en) 1994-02-03 2004-09-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
CN104628617B (zh) * 2015-02-12 2016-04-06 佛山市赛维斯医药科技有限公司 N-金刚烷酰胺类葡萄糖激酶活化剂、制备方法及其用途
CN104693084B (zh) * 2015-02-12 2016-03-16 佛山市赛维斯医药科技有限公司 含腈基苯基的n-金刚烷酰胺类化合物、其制备方法及用途
CN104628616B (zh) * 2015-02-12 2016-06-01 佛山市赛维斯医药科技有限公司 含对硝基苯基的n-金刚烷酰胺类化合物、其制备方法及用途
CN104628615B (zh) * 2015-02-12 2016-04-06 佛山市赛维斯医药科技有限公司 含卤代苯的n-金刚烷酰胺类化合物、其制备方法及其用途

Also Published As

Publication number Publication date
AT257633B (de) 1967-10-10
FR4976M (de) 1967-04-10
NL125066C (de)
DE1235904B (de) 1967-03-09
ES315990A1 (es) 1966-04-01
US3270054A (en) 1966-08-30
ES315989A1 (es) 1966-04-01
NL6509927A (de) 1966-02-01
AT257632B (de) 1967-10-10
GB1063749A (en) 1967-03-30
BE667692A (de) 1966-01-31

Similar Documents

Publication Publication Date Title
AT257634B (de) Verfahren zur Herstellung von neuen Guanidinderivaten und ihren Salzen
AT261582B (de) Verfahren zur Herstellung von neuen Alkanolaminderivaten und ihren Säureadditionssalzen
AT260257B (de) Verfahren zur Herstellung von neuen Indolderivaten und ihren Additonssalzen
AT267521B (de) Verfahren zur Herstellung von neuen 2-Halogen-benzimidazolen und ihren Salzen
AT284110B (de) Verfahren zur Herstellung von neuen N-Phenylindolinderivaten und ihren Salzen
AT257592B (de) Verfahren zur Herstellung von neuen Benzimidazolderivaten und ihren Salzen
AT284837B (de) Verfahren zur herstellung von neuen 2-halogen-alkyl-5-nitroimidazol-derivaten und ihren salzen
AT262303B (de) Verfahren zur Herstellung von neuen 1-Phenyl-cyclohexanderivaten und ihren Salzen
AT280268B (de) Verfahren zur Herstellung von neuen Rhodanpyrrolen und ihren Salzen
AT255414B (de) Verfahren zur Herstellung von neuen Hydrazino-2-thiazolinen und ihren Salzen
AT256096B (de) Verfahren zur Herstellung von neuen Indolderivaten und ihren Salzen
AT285591B (de) Verfahren zur Herstellung von neuen Spiro-azatetramethylenderivaten und ihren Salzen
AT257572B (de) Verfahren zur Herstellung von neuen Acetamidinderivaten und deren Salzen
AT294814B (de) Verfahren zur Herstellung von neuen 5-Nitrofuranderivaten und ihren Salzen
AT275539B (de) Verfahren zur Herstellung von neuen 6,11-Diamino-morphanthridinen und ihren Salzen
AT278030B (de) Verfahren zur herstellung von neuen benzolsulfonylharnstoffen und ihren salzen
AT259549B (de) Verfahren zur Herstellung von neuen Nitrofuranderivaten und ihren Salzen
AT255428B (de) Verfahren zur Herstellung von neuen Phenothiazinderivaten und ihren Salzen
AT261608B (de) Verfahren zur Herstellung von neuen Oxadiazol-Derivaten und ihren Salzen
AT273948B (de) Verfahren zur Herstellung von neuen Sulfonamiden und ihren Salzen
AT269863B (de) Verfahren zur Herstellung von neuen Sulfonamiden und ihren Salzen
AT289807B (de) Verfahren zur Herstellung von neuen Benzoxazepinonen und ihren Salzen
AT258907B (de) Verfahren zur Herstellung von neuen Aza-dibenzocycloheptenderivaten und ihren Salzen
AT256110B (de) Verfahren zur Herstellung von neuen Aza-dibenzocycloheptenderivaten und ihren Salzen
AT269138B (de) Verfahren zur Herstellung von neuen bis-Chromonylverbindungen und ihren Salzen